161 related articles for article (PubMed ID: 28475688)
21. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
22. Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling.
Dia VP; Gonzalez de Mejia E
Cancer Lett; 2011 Dec; 313(2):167-80. PubMed ID: 21963225
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.
Ma JL; Zeng S; Zhang Y; Deng GL; Shen H
Tumour Biol; 2016 May; 37(5):6177-84. PubMed ID: 26614432
[TBL] [Abstract][Full Text] [Related]
24. A20 inhibits the motility of HCC cells induced by TNF-α.
Wang X; Ma C; Zong Z; Xiao Y; Li N; Guo C; Zhang L; Shi Y
Oncotarget; 2016 Mar; 7(12):14742-54. PubMed ID: 26909601
[TBL] [Abstract][Full Text] [Related]
25. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
26. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma.
El Sayed I; Helmy MW; El-Abhar HS
Life Sci; 2018 Nov; 213():248-257. PubMed ID: 30292831
[TBL] [Abstract][Full Text] [Related]
28. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
[TBL] [Abstract][Full Text] [Related]
29. Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells.
Li T; Xu WS; Wu GS; Chen XP; Wang YT; Lu JJ
Asian Pac J Cancer Prev; 2014; 15(4):1745-9. PubMed ID: 24641402
[TBL] [Abstract][Full Text] [Related]
30. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
Wang Y; Yuan L; Yang XM; Wei D; Wang B; Sun XX; Feng F; Nan G; Wang Y; Chen ZN; Bian H
Clin Exp Metastasis; 2015 Jan; 32(1):39-53. PubMed ID: 25424030
[TBL] [Abstract][Full Text] [Related]
31. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.
Li X; Lin Z; Zhang B; Guo L; Liu S; Li H; Zhang J; Ye Q
Sci Rep; 2016 Feb; 6():21010. PubMed ID: 26867799
[TBL] [Abstract][Full Text] [Related]
32. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Huo S; Yu H; Li C; Zhang J; Liu T
Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
34. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
35. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness.
Zhang Y; Hu MY; Wu WZ; Wang ZJ; Zhou K; Zha XL; Liu KD
J Cancer Res Clin Oncol; 2006 Nov; 132(11):685-97. PubMed ID: 16786358
[TBL] [Abstract][Full Text] [Related]
36. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
37. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
38. C(16)-Ceramide-induced F-actin regulation stimulates mouse embryonic stem cell migration: involvement of N-WASP/Cdc42/Arp2/3 complex and cofilin-1/α-actinin.
Park SS; Kim MO; Yun SP; Ryu JM; Park JH; Seo BN; Jeon JH; Han HJ
Biochim Biophys Acta; 2013 Feb; 1831(2):350-60. PubMed ID: 22989773
[TBL] [Abstract][Full Text] [Related]
39. β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
Tian T; Li CL; Fu X; Wang SH; Lu J; Guo H; Yao Y; Nan KJ; Yang YJ
J Int Med Res; 2018 Apr; 46(4):1311-1325. PubMed ID: 29332411
[TBL] [Abstract][Full Text] [Related]
40. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
